AI Echo For Cardiac Amyloidosis

AI Echo for Cardiac Amyloidosis

Transthyretin (ATTR) amyloidosis is emerging as an under recognized form of heart failure especially in the elderly.  The aim of the study was to assess the ability of to assess prognosis, in this patient population, at the University College London National Amyloidosis Centre, the largest center worldwide for cardiac amylodosis.

AI Echo Results For Cardiac Amyloidosis
View Video on AI Echo Results For Cardiac Amyloidosis

“With software, in a little more than 24 hours, we analyzed all echos of more than 1,200 patients with ATTR Amyloidosis, completely automated, with no human interaction.”

See the video or download the results.